No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - RBC Capital Markets lifted its price target on Bodycote on Thursday to 775p from 650p and reiterated its 'outperform' rating following the company's results a day earlier.
The bank said Bodycote reported a solid first-half update and full-year outlook.
"Restructuring is moving ahead of expectations, as is footprint rationalisation," RBC said. "End markets have stabilised in recent months and some sequential uplift is expected in H2."
It argued that a price-to-earnings of 14x 25E/12x 26E for a business approaching 20% operating margins remains "highly attractive".
RBC said it was making limited forecast changes mainly around FX and restructuring/site rationalisation.
It lifted its price target as it updated its target multiple to 15x - in line with the Bodycote 10-year average - and rolled forward its base year to 2026.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.